Coronary Pressure Market Research Report, By Device (Sphygmomanometer, Automated Blood Pressure Monitor, BP Transducers, Ambulatory Blood Pressure Monitor), By Technology (Digital, Aneroid, Wearable), By End User (Hospitals) - Global Forecast till 2027
Market Highlights
The patients suffering from hypertension, diabetes, and other cardiovascular diseases uses coronary pressure monitors to examine the coronary blood pressure. These devices are gaining huge attention due to increasing patient population suffering from cardiovascular diseases and obesity related problem. In 2015, according to the World Health Organization, over 17.7 million patients died from cardiovascular diseases accounting for 31% of the total deaths and it is estimated that about 39% of the adults aged above 18 were overweight in 2016. Several other factors such as growing geriatric population and increasing use of non-invasive devices fuels the market. However, erroneous readings by coronary pressure monitoring devices may restrain the market growth during the forecasted period.
The global market for coronary pressure monitor is expected to grow at a CAGR of 6.65% during the review period.
Segmentation
The global coronary pressure monitors market is segmented on the basis of devices, technology, and end users.
On the basis of the devices, the market is segmented into sphygmomanometer, automated blood pressure monitor, BP transducers, ambulatory blood pressure monitor, instruments & accessories, and others.
On the basis of the technology, the market is segmented into digital, aneroid, wearable, and others.
On the basis of the end users, the market is segmented into hospitals, cardiac care centers, ambulatory centers & home care, academic institutes, and others.
Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/4768
Regional Analysis
The Americas dominate the global coronary pressure monitors market owing to a large patient population, strong government support for research & development, and high healthcare spending. According to the Center for Disease Control and Prevention in 2015, over 630,000 Americans died from heart disease, which represented 1 in every 4 deaths.
Europe is the second leading region in the global coronary pressure monitors market, which is followed by Asia Pacific. Asia Pacific is the fastest growing coronary pressure monitors market. Regionally, Europe is divided into Western Europe and Eastern Europe. Western Europe is holding the major share of the market, which is majorly contributed by Germany, the U.K., and France. However, Eastern Europe is the fastest growing region due the huge opportunities in the untapped market.
The Middle East and Africa contribute the least to the growth of the global coronary pressure monitors market. The Middle East dominates the market in this region. Whereas, Africa holds the least share of the global market due to limited availability of medical facilities and poor economic condition and stringent government policies. However, the growth of the African market is high due to the presence of opportunities for the development of the market.
Key Players
The key players for the global coronary pressure monitor market are Koninklijke Philips N.V. (Europe), General Electric Company (United States), Medtronic (Europe), Omron Corporation (Asia Pacific), A&D Medical Inc. (Asia Pacific), Drägerwerk AG & Co. KGaA (Europe), Rossmax International Ltd. (Asia Pacific), American Diagnostics Corp. (U.S.), and others.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/coronary-pressure-monitors-market-4768
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: [email protected]
The Global Coronary Stent Market is predicted to reach USD 15.18 billion by 2024 owing to factors include technological advancements, rising load of CAD, growing number of PCI procedures (percutaneous coronary intervention), increasing geriatric population and increasing demand for user-friendly procedures.
This helps the artery to open and stabilize the blood flow to the heart.
The Coronary stents are used in the treatment of cardiac disorders like angina pain, myocardial infarction and coronary artery disease.
The Coronary Stent Market is expected to grow significantly with CAGR of 6.2% in the forecast period.Request a Free Sample Copy of Coronary Stent Market Report @ https://www.millioninsights.com/industry-reports/coronary-stent-market-size/request-sampleThe Coronary Stent prevents the heart attack that is caused by the narrowing of coronary arteries.
The stent is made of cobalt alloy or stainless steel tube and is attached to small balloons that support to proper blood flow and take care of the vessel wall.
Owing to the rising elderly population across globe, particularly in the developed economies, the market expects wide opportunities in the different parts of the world.
Coronary Microcatheters Market report published by Value Market Research, which studies the future outlook of the market.
It includes the size, share, growth, trends, key players, segments and regional analysis in detail during the study year 2020-2027.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the coronary microcatheters market include Cook Medical, BrosMed Medical Co., Ltd., Merit Medical Systems, and Biometrics.
This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Coronary Microcatheters Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/coronary-microcatheters-market/download-sampleMarket DynamicsThe market is mainly driven by the rising prevalence of chronic heart diseases, and the increasing target patient population is one of the significant factors driving the growth of the market.
In addition to this, technological advancement force to the development of new and advanced products, which can boost the growth of the market.
Other factors that contributed to the growth of this market are increasing healthcare awareness, expansion of hospitals.
Global Coronary Stent Market Trending in 2021New York, NY 05 Oct 2021: The global coronary stent market size is expected to reach USD 15.28 billion by 2027 according to a new study by Polaris Market Research.
The report “Coronary Stent Market Share, Size, Trends, Industry Analysis Report, By Product (Drug Eluting, Bioresorbable Vascular Scaffold, Bare Metal Stents); By Metal (Cobalt Chromium, Platinum Chromium, Nickel Titanium, and Stainless Steel); By End Use (Hospitals, Ambulatory Surgical Centers, and Cardiology Centers); By Regions; Segment Forecast, 2020 – 2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.The global Coronary Stent Market offers prominent opportunities for the players to flourish in the untapped low-income countries, particularly in the Asia Pacific region.
Market is characterized by intense competition, flooded with many local players that develop safe, cost-effective, easy to use, and widely available products.
For example, The Frankel Cardiovascular Center, has 4 cardiac catheterization laboratory that are used for coronary procedures, these labs complement two hybrid operating rooms.
These medical facilities use technologically advanced such as DES, BMS and Bioresorbable Vascular Scaffold stents to improve the quality of life, offer better patient healthcare benefits like efficacy and safety profile, and minimize hospital stays.
For Example, Absorb GT1 has clinically proven that the artery is able to dilate and contract, called vasomotion that is similar to healthy blood vessels.
